Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Mersana Therapeutics, Inc. | 0 | reported | 06 Jan 2026 | tx 38+759,416−165,439 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | TENDER | Mersana Therapeutics, Inc. | 2,927 | — | |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,750 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,500 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 3,515 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 7,734 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 2,646 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,053 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 5,246 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,190 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 700 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 9,309 | — | deriv |
| 06 Jan 2026 | OTHER | Mersana Therapeutics, Inc. | 1,853 | — | deriv |
| 27 Oct 2025 | SALE | Mersana Therapeutics, Inc. | 77 | 9.90 USD | |
| 25 Oct 2025 | EXERCISE | Mersana Therapeutics, Inc. | 250 | 0.00 USD | |
| 25 Oct 2025 | EXERCISE | Mersana Therapeutics, Inc. | 250 | 0.00 USD | deriv |
| 15 Jan 2025 | EXERCISE | Mersana Therapeutics, Inc. | 14,583 | 0.00 USD | |
| 16 Jan 2025 | SALE | Mersana Therapeutics, Inc. | 5,939 | 0.58 USD | |
| 15 Jan 2025 | GRANT_AWARD | Mersana Therapeutics, Inc. | 281,250 | 0.00 USD | deriv |
| 15 Jan 2025 | EXERCISE | Mersana Therapeutics, Inc. | 14,583 | 0.00 USD | deriv |
| 15 Jan 2025 | GRANT_AWARD | Mersana Therapeutics, Inc. | 62,500 | 0.00 USD | deriv |
| 13 Jan 2025 | EXERCISE | Mersana Therapeutics, Inc. | 8,750 | 0.00 USD | |
| 14 Jan 2025 | SALE | Mersana Therapeutics, Inc. | 3,253 | 0.66 USD | |
| 13 Jan 2025 | EXERCISE | Mersana Therapeutics, Inc. | 8,750 | 0.00 USD | deriv |
| 28 Oct 2024 | SALE | Mersana Therapeutics, Inc. | 1,884 | 1.90 USD | |
| 25 Oct 2024 | EXERCISE | Mersana Therapeutics, Inc. | 6,250 | 0.00 USD |